Fred Hutch honors thirteen graduate students

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THIRTEEN GRADUATE STUDENTS received the 2014 Harold M. Weintraub Graduate Student Award sponsored by the Basic Sciences Division of Fred Hutchinson Cancer Research Center.

The recipients, all advanced students at or near the completion of their studies in the biological sciences, will participate in a scientific symposium May 2 at Fred Hutch consisting of scientific presentations by the awardees.

The award recipients will receive a certificate, travel expenses and an honorarium from the Weintraub and Groudine Fund, established to foster intellectual exchange through the promotion of programs for graduate students, fellows and visiting scholars.

The 2014 Harold M. Weintraub Graduate Student Award Recipients follow:

  • Andrew Adey, of the University of Washington, Ph.D. in molecular and cellular biology
  • Colin Conine, of the University of Massachusetts, Ph.D. candidate in molecular biology and genetics
  • Daniel Hochbaum, of Harvard University, Ph.D. candidate in engineering/applied sciences/applied physics
  • Hidehiko Inagaki, of the California Institute of Technology, Ph.D. candidate in biology
  • Liron Bar-Peled, of the Massachusetts Institute of Technology, Ph.D. in biology
  • Nora Pencheva, of The Rockefeller University, Ph.D. candidate in molecular biology
  • Alistair Russell, of the University of Washington, Ph.D. candidate in microbiology
  • Andrew Stergachis, of the University of Washington, Ph.D. candidate in genome sciences
  • Emma Watson, of the University of Massachusetts, Ph.D. candidate in systems biology
  • Kipp Weiskopf, of Stanford University, Ph.D. candidate in stem cell biology/regenerative medicine/cancer biology
  • Sarah Wilson, of the University of California, Berkeley, Ph.D. candidate in molecular and cell biology
  • Jiaxi Wu, of the UT Southwestern Medical Center, Ph.D. candidate in genetics and development
  • Swathi Yadlapalli, of the University of Michigan, Ph.D. candidate in cell and developmental biology

YOU MAY BE INTERESTED IN

In his first sit-down interview since beginning his role as FDA commissioner 17 days earlier, Marty Makary, a former Johns Hopkins surgeon and the only Trump pick for HHS whose confirmation received Democratic support, said he would speed up approvals for rare-disease treatments by reducing reliance on animal testing and shifting towards organoids and computational models. 
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login